v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities        
Net income (loss) $ (3,214) $ (2,243) $ 1,617 $ (10,978)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization expense 3,367 2,725 9,268 10,851
Amortization of discount on convertible notes 190 167 542 519
Amortization of premium on convertible notes (440) (414) (1,300) (1,224)
Accretion on marketable securities, net (269) 0 (1,136) 0
Stock-based compensation expense 4,327 6,327 12,333 18,772
Provision for expected credit losses 816 (229) 2,540 2,299
Gain on convertible notes extinguishment 0 0 0 (3,931)
Real estate and software contract restructuring costs 773 0 773 0
Changes in operating assets and liabilities:        
Accounts receivable 3,333 3,740 (130) (2,245)
Prepaid expenses and other assets (1,789) (3,359) (1,900) (6,284)
Deferred commissions (6) 1,158 1,968 3,840
Accounts payable (2,662) 1,012 (2,722) 2,134
Accrued and other liabilities 5,869 (1,772) 1,725 (1,831)
Deferred revenue (931) 3,441 9,252 12,589
Net cash provided by operating activities 9,364 10,553 32,830 24,511
Cash flows from investing activities:        
Cash paid for website domain name 0 0 0 (2,444)
Purchase of capitalized internal-use software, leasehold improvements, and property and equipment (3,628) (2,967) (12,955) (5,443)
Maturity of marketable securities 30,000 40,500 73,000 82,079
Purchase of marketable securities 0 (44,329) (44,765) (84,846)
Net cash provided by (used in) investing activities 26,372 (6,796) 15,280 (10,654)
Cash flows from financing activities:        
Proceeds from exercise of stock options 4 440 556 3,509
Taxes paid related to net share settlement of equity awards (360) (550) (1,120) (1,901)
Payment of convertible note issuance costs 0 0 0 (217)
Repayment of convertible notes and financing obligation 0 0 0 (54,528)
Net cash used in financing activities (356) (110) (564) (53,137)
Net change in cash and cash equivalents and restricted cash 35,380 3,647 47,546 (39,280)
Cash and cash equivalents and restricted cash, beginning of period 58,329 47,429 46,163 90,356
Cash and cash equivalents and restricted cash, end of period 93,709 51,076 93,709 51,076
Noncash investing and financing activities:        
Capital additions, accrued but not paid 664 805 664 805
Right-of-use asset obtained in exchange for new operating lease liability 0 698 0 6,213
Nonrelated Party        
Supplemental cash flow information:        
Cash paid for interest 0 0 5 0
Related Party        
Supplemental cash flow information:        
Cash paid for interest $ 0 $ 0 $ 5,625 $ 5,685